Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 3—March 2026
Dispatch
Emerging Endemic Area for Blastomycosis, New York, USA, 2000–2024
Table 1
Demographic characteristics and underlying conditions for 54 patients with laboratory-confirmed blastomycosis reported in Albany, New York, USA, 2000–2024*
| Characteristics |
Value |
|---|---|
| Mean age + SD, y | 43 + 18 |
| Median age, y (range) |
42 (4–78) |
| Sex | |
| F | 12 (22) |
| M |
42 (78) |
| Average BMI + SD | 27 + 6 |
| Median BMI (range) |
26 (16.9–39.7) |
| Race | |
| Caucasian | 37 (69) |
| African American | 9 (17) |
| Asian | 2 (4) |
| Other |
6 (11) |
| Underlying conditions | |
| Chronic lung disease | 10 (19) |
| Diabetes mellitus | 9 (17) |
| Cardiovascular disease | 4 (7) |
| Malignancy | 4 (7) |
| Immunosuppression | 2 (4) |
| Organ transplant | 1 (2) |
| HIV | 1 (2) |
| Kidney disease and failure | 2 (4) |
| Pregnancy | 1 (2) |
| None identified | 31 (57) |
| Tobacco use | 30 (55) |
| Marijuana use |
9 (15) |
| Preliminary diagnoses, n = 46 | |
| Community-acquired pneumonia | 14 (30) |
| Malignancy | 12 (26) |
| Skin and soft tissue infection | 5 (11) |
| Osteomyelitis | 4 (9) |
| Bacterial and viral infection | 3 (7) |
| Tuberculosis | 1 (2) |
| Blastomycosis | 1 (2) |
| Other | 6 (13) |
*Values are no. (%) except as indicated. Categories are not mutually exclusive, so totals may sum to >100%.
Page created: February 11, 2026
Page updated: February 26, 2026
Page reviewed: February 26, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.